Today: 7 February 2026
Subscribe
Browse Category

Financial Forecasts News 7 January 2026 - 6 February 2026

Bloom Energy stock whipsaws after big 2026 forecast — what traders watch next

Bloom Energy stock whipsaws after big 2026 forecast — what traders watch next

Bloom Energy shares reversed a 15.9% early surge Friday, falling 0.7% to $135.64 after the company set a 2026 revenue forecast of $3.1–$3.3 billion and reported a $6 billion backlog. Volume hit 15 million shares. Bloom posted Q4 revenue of $777.7 million and full-year revenue of $2.02 billion. The company announced a partnership with Oracle and a $5 billion AI infrastructure alliance with Brookfield.
6 February 2026
·····
Eli Lilly stock price jumps 10% after-hours on upbeat 2026 forecast and Q4 beat

Eli Lilly stock price jumps 10% after-hours on upbeat 2026 forecast and Q4 beat

Eli Lilly shares jumped 10.4% to $1,107.12 in after-hours trading Wednesday after reporting fourth-quarter revenue up 43% to $19.29 billion and a 2026 profit outlook above Wall Street forecasts. The company expects 2026 revenue of $80–83 billion and non-GAAP earnings per share of $33.50–$35.00. Mounjaro sales reached $7.41 billion and Zepbound $4.26 billion for the quarter.
4 February 2026
·····
SanDisk stock jumps as AI memory shortage fuels a bold Q3 forecast

SanDisk stock jumps as AI memory shortage fuels a bold Q3 forecast

SanDisk forecast third-quarter revenue of $4.4–$4.8 billion and non-GAAP EPS of $12–$14, sending shares up over 9% after hours. The company posted $3.025 billion revenue and $803 million net profit for Q2, reversing a prior loss. SanDisk extended its Kioxia joint venture to 2034 and committed $1.165 billion to manufacturing services. Memory chip prices are surging amid an “unprecedented” shortage, driven by AI data center demand.
3 February 2026
····
DaVita stock jumps after hours on upbeat 2026 profit forecast and earnings beat

DaVita stock jumps after hours on upbeat 2026 profit forecast and earnings beat

DaVita shares rose 11.7% to $124.17 in after-hours trading after posting quarterly earnings and a 2026 profit forecast above analyst estimates. The company reported fourth-quarter adjusted profit of $3.40 per share on $3.62 billion in revenue. DaVita projected 2026 adjusted earnings of $13.60 to $15.00 per share, topping the $12.65 consensus. Investors await details on reimbursement, costs, and patient volumes.
2 February 2026
·····
Colgate-Palmolive stock price jumps 5% after earnings beat and upbeat 2026 sales forecast

Colgate-Palmolive stock price jumps 5% after earnings beat and upbeat 2026 sales forecast

Colgate-Palmolive shares rose 5.2% to $89.70 Friday after the company beat Q4 profit forecasts and projected 2026 net sales growth of 2% to 6%. A $794 million after-tax impairment charge pushed GAAP results to a quarterly loss. Q4 net sales reached $5.23 billion, with adjusted earnings of 95 cents per share. Demand held steady in Latin America and Europe, while North American volumes stayed flat.
30 January 2026
·····
Intuitive Surgical stock price: what to watch Monday after ISRG’s 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical stock price: what to watch Monday after ISRG’s 2026 da Vinci outlook and tariffs hit focus

New York, Jan 25, 2026, 15:28 EST — Market closed. Intuitive Surgical (ISRG) shares closed Friday at $523.99, slipping roughly 0.4% following the company’s cautious growth forecast for 2026. U.S. markets will resume trading on Monday. The main question now: Is Intuitive’s forecast for procedure growth cautious, or a sign that hospital demand is genuinely slowing? “Procedure growth” measures how many surgeries use its systems, a key figure since it fuels recurring sales of instruments, accessories, and service. Leerink Partners’ Mike Kratky said the guidance “leaves room for upside,” boosting his price target to $622 from $600, while maintaining an
25 January 2026
·····
GSK share price in focus after China clears Trelegy for asthma — what to watch next week

GSK share price in focus after China clears Trelegy for asthma — what to watch next week

London, Jan 24, 2026, 07:58 GMT — Market closed GSK plc shares slipped 0.2% to 1,801 pence on Friday following news that China approved Trelegy Ellipta for adults with uncontrolled asthma. With London trading closed for the weekend, investors will have to wait until Monday to assess the impact of the new label. (GSK) The approval is significant as it expands GSK’s key respiratory brand further into China, where the company estimates about 46 million adults suffer from asthma, with roughly half experiencing poorly controlled symptoms. GSK highlighted that this move makes Trelegy the only “single-inhaler triple therapy”—combining three medicines
24 January 2026
······
Morgan Stanley Upgrade Lifts MDA Space as 2026 Space-Tech Funding Forecast Rises

Morgan Stanley Upgrade Lifts MDA Space as 2026 Space-Tech Funding Forecast Rises

TORONTO, Jan 19, 2026, 11:19 EST Global investment in space technology is set to climb again in 2026 after a record year, driven by defense-linked satellite systems and launch capacity, investment firm Seraphim Space said on Monday. Private investment rose 48% in 2025 to $12.4 billion, the firm said, and “a potential SpaceX IPO could act as a powerful catalyst,” said Seraphim Space investment analyst Lucas Bishop. The update lands as Canada’s MDA Space jumped 14.5% on Friday after Morgan Stanley upgraded the stock, a move that helped keep Toronto’s main index near record levels. (Reuters) Morgan Stanley’s space team,
19 January 2026
········
Montage Technology (688008) shares back in play after AI-linked 2025 profit jump forecast

Montage Technology (688008) shares back in play after AI-linked 2025 profit jump forecast

Shanghai, Jan 18, 2026, 08:39 GMT+8 — Market closed Montage Technology Co., Ltd. reported a steep jump in full-year profit in a late-week filing, offering investors new insight into demand for its memory and server connectivity chips just before Monday’s mainland market reopening. This profit alert hits at a crucial moment, right at the start of China’s annual reporting season. Guidance during this period tends to shift valuations sharply — particularly for chip companies seen as stand-ins for AI infrastructure investment. Montage attributed the rise to stronger shipments of its interconnect chips—the crucial hardware that transfers data between components in
18 January 2026
·····
Intuitive Surgical stock slips again as 2026 da Vinci outlook keeps pressure on ISRG

Intuitive Surgical stock slips again as 2026 da Vinci outlook keeps pressure on ISRG

New York, January 15, 2026, 12:06 (EST) — Regular session Intuitive Surgical shares dropped once more on Thursday, continuing a selloff sparked by the company’s weaker growth forecast for procedures involving its da Vinci surgical robot. The stock slipped roughly 1% to $541.08 in midday trading, following a 2.7% drop on Wednesday. The procedure forecast is crucial because every da Vinci surgery drives repeat sales — the single-use instruments and accessories hospitals need for each operation. If that volume dips, the growth story shrinks, even if robot deliveries remain steady. Investors are weighing how quickly Intuitive can roll out its
15 January 2026
·····
SoFi stock price forecast: BofA’s $20.50 target clashes with Barclays’ $28 as earnings loom

SoFi stock price forecast: BofA’s $20.50 target clashes with Barclays’ $28 as earnings loom

New York, Jan 7, 2026, 15:46 ET — Regular session SoFi Technologies shares were down about 0.1% at $26.96 on Wednesday afternoon, with roughly 37.5 million shares traded. The stock ended Tuesday at $26.98, down 7.9% from Monday’s $29.28 close. Nasdaq The slide has put the SoFi stock price forecast back under a harsh light, with investors weighing dilution from the company’s latest equity raise against the case for faster growth into 2026. Earnings later this month are the next hard checkpoint, and the tape is telling traders to keep their seatbelts on. In a filing, SoFi said underwriters exercised
7 January 2026
·····
Oracle stock price forecast: Wall Street splits as UBS cuts to $280 and Jefferies sticks with $400

Oracle stock price forecast: Wall Street splits as UBS cuts to $280 and Jefferies sticks with $400

NEW YORK, January 7, 2026, 15:31 EST — Regular session Oracle shares were little changed on Wednesday as investors digested fresh analyst calls that painted a wide 12-month path for the stock. The shares were down 0.1% at $193.52 in mid-afternoon trade, after touching $195.49 earlier in the session. Why it matters now: Oracle has become a proxy for investor nerves around debt-funded AI data-center buildouts and customer concentration. UBS analyst Karl Keirstead cut his price target to $280 from $325 on Monday while keeping a “Buy” rating, saying the roughly 41% slide from mid-September highs showed confidence has cracked
7 January 2026
·····
1 2 3 … 68

Stock Market Today

AST SpaceMobile stock bounces late Friday as AT&T plays down Amazon Leo threat and a new 2x short ETF hits tape

AST SpaceMobile stock bounces late Friday as AT&T plays down Amazon Leo threat and a new 2x short ETF hits tape

7 February 2026
New York, February 6, 2026, 19:59 EST — After-hours AST SpaceMobile shares rose 9.1% to $101.79 in late trading on Friday, a sharp rebound after a week of fast moves. The stock ranged from $90.02 to $105.19, with about 15.9 million shares traded, market data showed. Why it matters now: AST’s valuation has become a proxy bet on whether big mobile carriers stick with its plan to connect ordinary phones directly to satellites, without special handsets. That makes the stock unusually sensitive to partner news, and to anything that hints at new competition. Direct-to-device is still more promise than proof
Go toTop